Citation Impact
Citing Papers
Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer
2009
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
Work in Brief
2006
Cutting Edge: NKG2ChiCD57+ NK Cells Respond Specifically to Acute Infection with Cytomegalovirus and Not Epstein–Barr Virus
2014
Molecular and clinical diversity in paraneoplastic immunity to Ma proteins
2001
Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival
2009
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
2014 Standout
The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse
2011
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
2012
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Epidemiology of pancreatic cancer: an overview
2009
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
2015 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Pancreatic cancer
2004 Standout
Paraneoplastic neurological degenerations: keys to tumour immunity
2004
FGFR3 mutations in prostate cancer: association with low-grade tumors
2009
Cancer burden in the year 2000. The global picture
2001 Standout
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours
2003 StandoutNature
Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity
2006
Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis
2009
Global Cancer Statistics, 2002
2005 Standout
TIC-Tox: A preliminary discussion on identifying the forcing agents of DBP-mediated toxicity of disinfected water
2017
STrengthening the Reporting of OBservational studies in Epidemiology: Molecular Epidemiology STROBE-ME. An extension of the STROBE statement
2011
Epidemiologic and etiologic factors of pancreatic cancer
2002
Total organic halogen (TOX) in human urine: A halogen-specific method for human exposure studies
2017
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Ten steps towards improving prognosis research
2009
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy
2003
Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma
1999
Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes
2013
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
2001
Individual Participant Data Meta-Analysis for a Binary Outcome: One-Stage or Two-Stage?
2013
Association Between Smoking and Risk of Bladder Cancer Among Men and Women
2011
Anti-Hu antibodies may indicate a positive response to chemotherapy in paraneoplastic syndrome secondary to small cell lung cancer
2003
STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE‐ME): An extension of the STROBE statement
2011
Recommended diagnostic criteria for paraneoplastic neurological syndromes
2004 Standout
The dynamic disulphide relay of quiescin sulphydryl oxidase
2012 StandoutNatureNobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
2010
Antineuronal Antibodies in Patients With Neuroblastoma and Paraneoplastic Opsoclonus-Myoclonus
2000
Epigenetic Modification and Antibody-Dependent Expansion of Memory-like NK Cells in Human Cytomegalovirus-Infected Individuals
2015
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
2012
Normal and neoplastic urothelial stem cells: getting to the root of the problem
2012
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Pancreatic Adenocarcinoma
2014 Standout
Paraneoplastic Neurologic Syndromes: Pathogenesis and Physiopathology
1999
Immune surveillance of tumors
2007
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer
2002
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Wood smoke exposure and risk of chronic obstructive pulmonary disease
2006
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Respiratory health consequences of environmental tobacco smoke
2004
Wnt/β-Catenin Signaling and Disease
2012 Standout
Immunomodulatory treatment trial for paraneoplastic neurologicaldisorders
2004
DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer
2002
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
2001
Human Cytomegalovirus Drives Epigenetic Imprinting of the IFNG Locus in NKG2Chi Natural Killer Cells
2014
Immunity, Inflammation, and Cancer
2010 Standout
Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
2008
Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data
2007
Tomatoes, Tomato-Based Products, Lycopene, and Cancer: Review of the Epidemiologic Literature
1999 Standout
Disposition of Bromodichloromethane in Humans Following Oral and Dermal Exposure
2007
Developing and validating risk prediction models in an individual participant data meta-analysis
2014
Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status
1999
Mechanisms of smoking-related lung and pancreatic adenocarcinoma development
2002
Wnt/β-Catenin Signaling in Development and Disease
2006 Standout
Prospects for the use of NK cells in immunotherapy of human cancer
2007
Environmental and personal determinants of the uptake of disinfection by-products during swimming
2016
Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function
2015
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
EphB–ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells
2007
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
2010
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond
2009
Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research
2013
Primer: an evidence-based approach to prognostic markers
2005
Spontaneous neurological improvement in anti-Hu associated encephalomyelitis.
1997
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Occurrence, genotoxicity, and carcinogenicity of regulated and emerging disinfection by-products in drinking water: A review and roadmap for research
2007 Standout
HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert–Eaton myasthenic syndrome
2004
A Population-Based, Case-Control Study of Polymorphisms in Carcinogen-Metabolizing Genes, Smoking, and Pancreatic Adenocarcinoma Risk
2002
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
2010 StandoutNature
Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer
2010
Crypt stem cells as the cells-of-origin of intestinal cancer
2008 StandoutNature
Stimulation of the aberrant expression of a paraneoplastic antigen, recoverin, in small cell lung cancer cell lines
2004
Utility of anti‐Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy
1998
Genetics and biology of pancreatic ductal adenocarcinoma
2006
Heterogeneous expression of Wnt/β‐catenin target genes within colorectal cancer
2007
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
2011
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Mass Spectrometry Identification of N-Chlorinated Dipeptides in Drinking Water
2017
Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations
2020
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Toxic Potential of Materials at the Nanolevel
2006 StandoutScience
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
The Three Es of Cancer Immunoediting
2004 Standout
Drinking Water Disinfection Byproducts (DBPs) and Human Health Effects: Multidisciplinary Challenges and Opportunities
2017 Standout
Trends in stage‐specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006
2013
Water disinfection by-products and bladder cancer: is there a European specificity? A pooled and meta-analysis of European case–control studies
2011
Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease
2003
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
ExBox: A Polycyclic Aromatic Hydrocarbon Scavenger
2012 StandoutNobel
Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors
2010
DNA vaccination with HuD inhibits growth of a neuroblastoma in mice.
1998
Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection
2014
Paraneoplastic Neurologic Disease Antigens: RNA-Binding Proteins and Signaling Proteins in Neuronal Degeneration
2001
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Relative Importance of N-Nitrosodimethylamine Compared to Total N-Nitrosamines in Drinking Waters
2013
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
2002
A Comprehensive Survey of Ras Mutations in Cancer
2012 Standout
Multidrug Resistance Protein 4 (MRP4/ABCC4) Protects Cells from the Toxic Effects of Halobenzoquinones
2017
Exploring Amino Acid Side Chain Decomposition Using Enzymatic Digestion and HPLC-MS: Combined Lysine Transformations in Chlorinated Waters
2009
A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery
2015
Clinical outcome of patients with anti-Hu–associated encephalomyelitis after treatment of the tumor
1999
Cancer Genome Landscapes
2013 StandoutScience
Chemical and Toxicological Characterization of Halobenzoquinones, an Emerging Class of Disinfection Byproducts
2015
Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air.
2002
Current View: Intestinal Stem Cells and Signaling
2008
[18F]Fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies
2000
Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors.
2000
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
Promotion of direct reprogramming by transformation-deficient Myc
2010 StandoutNobel
Progressive Increase in Disinfection Byproducts and Mutagenicity from Source to Tap to Swimming Pool and Spa Water: Impact of Human Inputs
2016
Coexistence of Quiescent and Active Adult Stem Cells in Mammals
2010 StandoutScience
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
KIR and disease: a model system or system of models?
2006
Chemical Glycoproteomics
2016 StandoutNobel
Development and application of a human PBPK model for bromodichloromethane to investigate the impacts of multi‐route exposure
2015
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Occurrence and Toxicity of Disinfection Byproducts in European Drinking Waters in Relation with the HIWATE Epidemiology Study
2012
DNA adducts in human pancreatic tissues and their potential role in carcinogenesis.
1998
Works of Núria Malats being referenced
Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study
2007
PIK3CA Mutations Are an Early Genetic Alteration Associated with FGFR3 Mutations in Superficial Papillary Bladder Tumors
2006
Smoking and Bladder Cancer in Spain: Effects of Tobacco Type, Timing, Environmental Tobacco Smoke, and Gender
2006
Biomarkers of exposure to polycyclic aromatic hydrocarbons from environmental air pollution
2004
Lifetime history of alcohol consumption and K‐ras mutations in pancreatic ductal adenocarcinoma
2009
Ki-ras mutations in exocrine pancreatic cancer: Association with clinico-pathological characteristics and with tobacco and alcohol consumption
1997
Timing of blood extraction in epidemiologic and proteomic studies: results and proposals from the PANKRAS II Study
2007
Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stage
2005
Occurrence, trends and environmental etiology of pancreatic cancer
1998
Occupation and bladder cancer in a hospital-based case–control study in Spain
2007
Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research
2013
Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer
1999
Assessment of lifetime exposure to trihalomethanes through different routes
2006
Screening for bladder cancer: a perspective
2007
Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology
2000
Air pollution and risk of urinary bladder cancer in a case-control study in Spain
2007
Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
1997
Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer
2007
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
2005
Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study
2008
Occupation and pancreatic cancer in Spain: a case-control study based on job titles
2000
Bladder Cancer and Exposure to Water Disinfection By-Products through Ingestion, Bathing, Showering, and Swimming in Pools
2006
The International Bladder Cancer Bank: Proposal for a new study concept
2004
EphB receptor activity suppresses colorectal cancer progression
2005 Nature
Vegetable and fruit intake and the risk of lung cancer in women in Barcelona, Spain
1997
Genetic Susceptibility to Distinct Bladder Cancer Subphenotypes
2009
Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: Etiopathogenic similarities, differences and paradoxes
2009
Serum Anti-p53 Antibodies and Prognosis of Patients With Small-Cell Lung Cancer
1997
Cystic fibrosis transmembrane regulator ( CFTR ) ΔF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer
2001
FGFR3 and Tp53 Mutations in T1G3 Transitional Bladder Carcinomas: Independent Distribution and Lack of Association with Prognosis
2005
Ambient air pollution and incident bladder cancer risk: Updated analysis of the Spanish Bladder Cancer Study
2019
Polymorphisms in GSTT1 , GSTZ1 , and CYP2E1 , Disinfection By-products, and Risk of Bladder Cancer in Spain
2010
Review of studies of selected metabolic polymorphisms and cancer.
1999
PIK3CA MUTATIONS ARE AN EARLY GENETIC ALTERATION ASSOCIATED WITH FGFR3 MUTATIONS IN SUPERFICIAL PAPILLARY BLADDER TUMORS
2006
Overall evaluation and research perspectives.
1999
Imprint of human cytomegalovirus infection on the NK cell receptor repertoire
2004
Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas
2006
Bladder Cancer, Disinfection Byproducts, and Markers of Genetic Susceptibility in a Case-control Study from Spain
2006
Concepts for Banking Tissue in Urologic Oncology—The International Bladder Cancer Bank
2005
Risk of pancreatic cancer and occupational exposures in Spain
2000
Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.
1999
Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism.
2000